Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Medicine | 3 | 2025 | 189 | 1.170 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 89 | 0.910 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2018 | 92 | 0.780 |
Why?
|
| Community-Acquired Infections | 3 | 2019 | 94 | 0.780 |
Why?
|
| Emergency Service, Hospital | 4 | 2018 | 1101 | 0.740 |
Why?
|
| Benchmarking | 2 | 2019 | 136 | 0.650 |
Why?
|
| Faculty, Medical | 2 | 2019 | 198 | 0.650 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2006 | 226 | 0.600 |
Why?
|
| Peer Review, Research | 1 | 2019 | 47 | 0.580 |
Why?
|
| Macrolides | 1 | 2018 | 38 | 0.560 |
Why?
|
| Length of Stay | 2 | 2018 | 812 | 0.510 |
Why?
|
| Research | 1 | 2017 | 193 | 0.500 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 317 | 0.480 |
Why?
|
| Respiratory Tract Infections | 2 | 2006 | 89 | 0.440 |
Why?
|
| Pneumonia, Pneumococcal | 3 | 2021 | 28 | 0.430 |
Why?
|
| Coronary Disease | 2 | 2006 | 246 | 0.420 |
Why?
|
| Emergency Treatment | 1 | 2013 | 57 | 0.390 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 790 | 0.380 |
Why?
|
| United States | 9 | 2025 | 7846 | 0.340 |
Why?
|
| Emergency Medical Services | 3 | 2017 | 266 | 0.330 |
Why?
|
| Mental Disorders | 1 | 2017 | 791 | 0.310 |
Why?
|
| Platelet Activation | 2 | 2008 | 27 | 0.300 |
Why?
|
| Publications | 2 | 2019 | 29 | 0.290 |
Why?
|
| Anti-Infective Agents | 3 | 2012 | 150 | 0.260 |
Why?
|
| Hospitalization | 5 | 2019 | 1364 | 0.260 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2006 | 24 | 0.240 |
Why?
|
| Mianserin | 1 | 2005 | 3 | 0.240 |
Why?
|
| Oxazolidinones | 1 | 2005 | 14 | 0.240 |
Why?
|
| Serotonin Syndrome | 1 | 2005 | 10 | 0.240 |
Why?
|
| Acetamides | 1 | 2005 | 13 | 0.240 |
Why?
|
| Citalopram | 1 | 2005 | 21 | 0.240 |
Why?
|
| Ticlopidine | 1 | 2006 | 49 | 0.240 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2006 | 168 | 0.230 |
Why?
|
| Internship and Residency | 2 | 2025 | 808 | 0.220 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 225 | 0.210 |
Why?
|
| Humans | 24 | 2025 | 63449 | 0.210 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 49 | 0.210 |
Why?
|
| Acute Disease | 5 | 2006 | 671 | 0.210 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 81 | 0.200 |
Why?
|
| Thrombosis | 2 | 2005 | 199 | 0.200 |
Why?
|
| Streptococcus pneumoniae | 2 | 2021 | 66 | 0.200 |
Why?
|
| Medication Adherence | 1 | 2004 | 203 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2025 | 352 | 0.190 |
Why?
|
| Pneumococcal Infections | 1 | 2021 | 38 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 724 | 0.160 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 26 | 0.150 |
Why?
|
| Hematemesis | 1 | 2018 | 6 | 0.150 |
Why?
|
| Pneumonia | 1 | 2021 | 291 | 0.150 |
Why?
|
| Endoscopy, Digestive System | 1 | 2018 | 33 | 0.140 |
Why?
|
| Capsule Endoscopy | 1 | 2018 | 35 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 47 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 916 | 0.140 |
Why?
|
| Crowding | 1 | 2018 | 34 | 0.140 |
Why?
|
| Colonoscopy | 1 | 2018 | 100 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2018 | 78 | 0.140 |
Why?
|
| Medically Uninsured | 1 | 2017 | 40 | 0.130 |
Why?
|
| Massachusetts | 3 | 2018 | 2075 | 0.130 |
Why?
|
| Patient Admission | 1 | 2018 | 198 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2017 | 93 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2017 | 152 | 0.120 |
Why?
|
| Middle Aged | 8 | 2019 | 17613 | 0.110 |
Why?
|
| Syndrome | 2 | 2006 | 180 | 0.110 |
Why?
|
| Peer Review, Health Care | 1 | 2014 | 17 | 0.110 |
Why?
|
| Administration, Oral | 2 | 2005 | 369 | 0.100 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2013 | 11 | 0.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2006 | 455 | 0.100 |
Why?
|
| Medicare | 1 | 2017 | 612 | 0.100 |
Why?
|
| Medical Errors | 1 | 2014 | 196 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 255 | 0.090 |
Why?
|
| Young Adult | 3 | 2019 | 4694 | 0.090 |
Why?
|
| Rhinitis | 1 | 2012 | 25 | 0.090 |
Why?
|
| Sinusitis | 1 | 2012 | 31 | 0.090 |
Why?
|
| Adolescent | 3 | 2021 | 6245 | 0.090 |
Why?
|
| Adult | 7 | 2021 | 16824 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 176 | 0.090 |
Why?
|
| Patient Safety | 1 | 2014 | 242 | 0.090 |
Why?
|
| Etomidate | 1 | 2011 | 8 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2021 | 3293 | 0.090 |
Why?
|
| Female | 10 | 2019 | 32881 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 196 | 0.090 |
Why?
|
| Pneumococcal Vaccines | 2 | 2021 | 20 | 0.080 |
Why?
|
| Serogroup | 2 | 2021 | 35 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2011 | 86 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2576 | 0.080 |
Why?
|
| Male | 9 | 2019 | 29891 | 0.080 |
Why?
|
| Critical Care | 1 | 2013 | 396 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1553 | 0.070 |
Why?
|
| Risk Factors | 3 | 2019 | 5354 | 0.070 |
Why?
|
| Sepsis | 1 | 2011 | 289 | 0.070 |
Why?
|
| Linezolid | 1 | 2005 | 6 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 23 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 142 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 139 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 245 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 298 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 1 | 2008 | 253 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 173 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2005 | 92 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 465 | 0.050 |
Why?
|
| Skin Diseases, Infectious | 1 | 2003 | 12 | 0.050 |
Why?
|
| Time Factors | 3 | 2018 | 3768 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2006 | 305 | 0.050 |
Why?
|
| Soft Tissue Infections | 1 | 2003 | 49 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2003 | 55 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2005 | 193 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 102 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 574 | 0.050 |
Why?
|
| Echocardiography, Doppler | 1 | 2003 | 133 | 0.050 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2001 | 14 | 0.050 |
Why?
|
| Mesenteric Veins | 1 | 2001 | 11 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2021 | 18 | 0.050 |
Why?
|
| Jugular Veins | 1 | 2001 | 29 | 0.050 |
Why?
|
| Registries | 1 | 2006 | 888 | 0.050 |
Why?
|
| Arm | 1 | 2001 | 46 | 0.050 |
Why?
|
| Aged | 5 | 2019 | 14447 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 59 | 0.040 |
Why?
|
| Cerebral Veins | 1 | 2001 | 36 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2018 | 6658 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2019 | 18 | 0.040 |
Why?
|
| Epidemiological Monitoring | 1 | 2019 | 31 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 49 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2019 | 162 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 183 | 0.030 |
Why?
|
| Heart Failure | 1 | 2003 | 913 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2018 | 519 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 5462 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 338 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2012 | 149 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 443 | 0.020 |
Why?
|
| Platelet Function Tests | 1 | 2008 | 11 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1645 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 1990 | 0.020 |
Why?
|
| Diflunisal | 1 | 1986 | 2 | 0.020 |
Why?
|
| Naproxen | 1 | 1986 | 6 | 0.020 |
Why?
|
| Salicylates | 1 | 1986 | 9 | 0.020 |
Why?
|
| Back Pain | 1 | 1986 | 51 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1147 | 0.010 |
Why?
|
| Systole | 1 | 2003 | 108 | 0.010 |
Why?
|
| Diastole | 1 | 2003 | 91 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 1408 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 331 | 0.010 |
Why?
|
| Child | 1 | 2012 | 4526 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 250 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2003 | 329 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 978 | 0.010 |
Why?
|
| Decision Making | 1 | 2003 | 407 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2003 | 512 | 0.010 |
Why?
|
| Sprains and Strains | 1 | 1986 | 8 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1986 | 33 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 199 | 0.000 |
Why?
|